Pathology of lymphoma progression.

Area of Science:

• Oncology
• Hematology
• Pathology

Background:

• Lymphoma progression is a stepwise process in oncogenesis where lymphomas acquire a more aggressive phenotype.
• Morphological changes in lymphoma often correlate with altered clinical and biological behavior.
• Lymphoma progression can involve clonally related or unrelated neoplasms.

Purpose of the Study:

• To define 'lymphoma progression' in a biological context, emphasizing clonal development.
• To differentiate 'lymphoma progression' from 'composite lymphoma', a morphological designation.
• To clarify the relationship between morphological changes and biological behavior in lymphoma.

Main Methods:

• Review of existing literature on lymphoma progression and morphology.
• Analysis of clinical and biological data associated with lymphoma changes.
• Proposed terminology for biological progression versus morphological description.

Main Results:

• Lymphoma progression is characterized by clonal evolution within a lymphoma entity.
• Composite lymphoma is a descriptive term for lymphomas of different entities in one patient, regardless of clonal origin.
• Aggressive B-cell non-Hodgkin's lymphomas and Hodgkin's lymphomas frequently arise secondary to lymphoma progression.
• Genetic alterations in progression often override differentiation, increasing cell proliferation.

Conclusions:

• Lymphoma progression should be defined biologically as clonal development.
• Composite lymphoma is a distinct morphological classification.
• Understanding lymphoma progression is crucial for managing aggressive variants and high-risk disease.